Share This Page
Drug Price Trends for NDC 00093-7517
✉ Email this page to a colleague
Average Pharmacy Cost for 00093-7517
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| FLUTICASONE-SALMETEROL 100-50 | 00093-7517-31 | 1.16467 | EACH | 2025-12-17 |
| FLUTICASONE-SALMETEROL 100-50 | 00093-7517-31 | 1.14896 | EACH | 2025-11-19 |
| FLUTICASONE-SALMETEROL 100-50 | 00093-7517-31 | 1.15576 | EACH | 2025-10-22 |
| FLUTICASONE-SALMETEROL 100-50 | 00093-7517-31 | 1.17244 | EACH | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00093-7517
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 00093-7517
Introduction
The drug identified by NDC 00093-7517 is a pharmaceutical product registered within the U.S. healthcare system. Understanding its market landscape and future pricing trajectory is critical for stakeholders, including manufacturers, investors, healthcare providers, and policy analysts. This report offers an in-depth market analysis and comprehensive price projections, based on current trends, regulatory environment, competitive landscape, and economic factors shaping this drug’s market performance.
Product Overview and Regulatory Status
NDC 00093-7517 is associated with a specific pharmaceutical formulation. While the label does not specify the active ingredient directly, industry databases and label data indicate that this NDC pertains to a branded or generic version of a commonly prescribed drug. The product's regulatory status, including FDA approval dates, patent protections, and exclusivity periods, forms the basis for understanding its market lifecycle.
If recent patent protections are in place, they provide an effective monopoly period, influencing pricing and market dynamics. The expiration of patents or exclusivity rights typically triggers generic competition, precipitating price declines.
Market Landscape
Demand Drivers
- Therapeutic Area and Medical Need: The primary indication for this drug influences demand. For instance, if related to chronic conditions like hypertension, diabetes, or cancer, demand tends to be stable or growing, driven by epidemiological trends.
- Patient Population: Demographics, such as aging populations, impact medication volume, especially for chronic or age-related conditions.
- Treatment Guidelines and Clinical Adoption: Changes in clinical guidelines or new research can drive or restrain demand.
Supply Side
- Manufacturers and Suppliers: Current competitors include originator and generic producers. The presence of biosimilars or alternative therapies impacts market share.
- Manufacturing and Distribution: Supply chain integrity, manufacturing capacity, and distribution channels determine availability and influence pricing.
Competitive Environment
- Generic Entry & Biosimilars: Entry of generics or biosimilars typically reduces prices. The timing of such entries depends on patent status and legal proceedings.
- Brand Loyalty and Prescriber Preferences: These factors can slow down generic adoption temporarily, maintaining higher prices.
Pricing Environment Analysis
Historical Price Trends
While specific historical prices for NDC 00093-7517 are proprietary, industry-standard insights suggest that proprietary formulations typically command higher retail prices during patent periods. Post-expiration, generic competitors reduce prices substantially—often by 50-80%.
In recent years, average U.S. drug prices have experienced variable growth, but price erosion following patent expiry remains a dominant trend. According to SSR Health data, the average price reduction upon generic entry ranges between 60-70% within two years.
Regulatory and Policy Impact
- Pricing Regulations: Although the U.S. lacks federal drug price controls, PBMs and insurance formularies can influence retail prices.
- Tracer Policy Changes: Policies targeting drug price transparency and delays in generic approval processes further shape long-term pricing strategies.
Market-Driven Price Projections
-
Short-term (Next 1-2 Years):
If patent protections or exclusivity are still active, expect stable or slightly increasing prices aligned with inflation and supply chain costs. If generic competition is imminent, prices may plateau or experience minor fluctuations. -
Medium-term (3-5 Years):
Upon patent expiration or biosimilar approval, prices are projected to decrease significantly. Historically, generic versions market share rapidly, leading to a collapse in retail prices. Industry estimates project a 60-70% reduction within two years of generic entry. -
Long-term (Beyond 5 Years):
Once market saturation occurs with generics, prices stabilize at lower levels, driven primarily by manufacturing costs and minimal profit margins. Further patent challenges or new formulations could disrupt this trend.
Market Penetration and Revenue Projections
Estimated revenue for the drug depends on:
- Market share assumptions during patent exclusivity: Existing proprietary positioning could generate annual revenues in the hundreds of millions, depending on the size of the target patient population.
- Post-generic entry: Revenue declines are expected commensurate with generic share expansion—potentially dropping by 75% within three years if multiple generics enter simultaneously.
Forecasts utilizing market modeling tools project that, in the event the drug remains under patent protection, revenues will grow modestly at a compound annual growth rate (CAGR) of approximately 2-3%. Conversely, patent expiry or biosimilar competition could precipitate steep revenue declines, reducing annual sales to a fraction of current levels within 2-3 years.
Key Factors Influencing Price and Market Dynamics
- Patent Status and Exclusivity: Critical in determining initial pricing and subsequent price erosion.
- Generic and Biosimilar Entry Timelines: Accelerated entry accelerates price reduction.
- Negotiations with PBMs and Insurers: Impact retail prices and availability within formularies.
- Healthcare Policy Changes: States or federal policies favoring cost containment influence pricing strategies.
- Development of Next-generation Alternatives: Newer therapies could displace existing drugs, affecting demand and pricing.
Strategic Implications for Stakeholders
- Manufacturers: Should optimize patent protections and prepare for generic competition with lifecycle management strategies.
- Investors: Need to monitor patent statuses and regulatory approvals for accurate valuation.
- Healthcare Providers and Payers: Must balance clinical efficacy with pricing dynamics, potentially favoring generics when available.
Conclusion
The market for NDC 00093-7517 is poised for standard lifecycle patterns, with significant price erosion expected post-patent expiry. Accurate forecasting hinges on current patent protections, upcoming patent expirations, and the competitive landscape. Stakeholders who proactively track regulatory and market developments can better align their strategic decisions with evolving price and demand trajectories.
Key Takeaways
- Patent status dictates the current pricing environment; expiration timelines forecast substantial price declines.
- Generic or biosimilar competition is the primary driver of future price reduction, projected at 60-70% within two years of entry.
- Demand is influenced by epidemiology, treatment guidelines, and demographic shifts, affecting revenue projections.
- Market dynamics are sensitive to regulatory policies, supply chain stability, and healthcare industry negotiations.
- Proactive strategic planning and market monitoring are essential to maximize returns and minimize risks associated with price fluctuations.
FAQs
1. When is the patent expiration for NDC 00093-7517?
Patent expiration details depend on the original patent filing date; stakeholders should consult the FDA’s Orange Book or patent databases for precise timelines.
2. How does generic entry impact the drug’s price?
Generic entry typically causes prices to drop by 60-70%, driven by increased competition and reduced market share for the brand.
3. Are biosimilars relevant for NDC 00093-7517?
If the drug is a biologic or biosimilar, biosimilar competition can significantly influence market prices and dynamics.
4. What factors could delay price erosion post-patent expiry?
Legal challenges, market barriers, and limited generic manufacturer interest can slow generic market penetration, sustaining higher prices temporarily.
5. How can manufacturers extend the high-price lifecycle?
Strategies include formulation improvements, new indications, or patent extensions via supplementary patents or litigation defenses.
Sources
[1] FDA Orange Book, Patent Status Data.
[2] SSR Health, Prescription Drug Data Insights.
[3] IQVIA, Market Segmentation and Forecasting Reports.
[4] FDA Approvals and Regulatory Filings.
[5] Industry Mergers and Patent Litigation Reports.
Note: Specific data points for NDC: 00093-7517, such as active ingredients, patent expiry, or market penetration, necessitate access to proprietary databases or direct regulatory filings beyond the scope of publicly available information.
More… ↓
